Double hit of new appointments for Head of Molecular Endocrinology and Pharmacology
By Alicia Bienkowski | Molecular Endocrinology and Pharmacology, Molecular Medicine, News & EventsPerkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) earlier this month. Coincidentally, on…
Perkins secures biobanking grants to answer important questions in future research
By Alicia Bienkowski | awards, Cancer, Cancer, Cancer Epigenetics, Centre for Diabetes Research, Diabetes, Diabetes, Funding, Inspiration, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Translational OncologyThe McGowan Government recently announced that the Harry Perkins Institute will receive two of the 16 grants totalling more than $1.5 million to support Western Australian biobanks. Congratulations to both…
Bioengineers deliver innovation award success
By Alicia Bienkowski | awards, Bioimaging Research and Innovation for Translational Engingeering BRITE, Biomedical engineering, Blood Vessels, Breast Cancer, Cancer, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Imaging and Therapy, Media Releases, News & Events, Vascular Biology and Stromal Targeting, Vascular EngineeringCombining engineering thinking with medical research has proved a winning formula for four Perth start-up companies linked to the Harry Perkins Institute of Medical Research in Nedlands. They were winners…
Tiny filters with big roles for patients with chronic kidney disease
By Alicia Bienkowski | Biomedical engineering, Blood Vessels, Cardiovascular Disease, Cardiovascular Disease, Cardiovascular Science and Diabetes Program, Chronic Kidney Disease, Disease Area, Kidney Disease, Kidneys, Media Releases, News & Events, Vascular EngineeringPerth bioengineers investigate critical device for dialysis machines Fast facts An estimated 1.7 million or 10% of Australian adults have Chronic Kidney Disease (CKD) An estimated 1 in 5 or…
$20M for biopharm DIMERIX to fund phase 3 trials for rare kidney disease
By Alicia Bienkowski | Chronic Kidney Disease, Funding, Kidney Disease, Kidneys, Media Releases, Molecular Endocrinology and Pharmacology, Molecular Medicine, News & Events, Research AreaBiopharmaceutical company, Dimerix (ASX: DXB), which is developing new treatments for types of inflammatory kidney and respiratory diseases, announced it has successfully raised $20 million to fund Phase 3 trials…
Dual win sees two Harry Perkins researchers awarded in 2020 Business Events Perth Aspire Awards
By Alicia Bienkowski | Epigenetics and Genomics Laboratory, Media Releases, Molecular Endocrinology and Pharmacology, News & EventsBusiness Events Perth, in partnership with the Harry Perkins Institute of Medical Research, is pleased to announce that the inaugural Harry Perkins Aspire Award has been presented to two applicants:…
Australian drug chosen for global trial to treat COVID-19
By Alicia Bienkowski | Lab, Molecular Endocrinology and Pharmacology, News & Events, ResearchA drug developed by Perkins and UWA spinout company Dimerix will be used in a global trial to treat patients who have Acute Respiratory Distress Syndrome (ARDS) as a result…
Game-changing study shows ‘hands off’ approach’ best to treat a collapsed lung
By Alicia Bienkowski | Centre for Clinical Research in Emergency Medicine, Emergency Medicine, Lungs, Media Releases, News & Events, Research, StatementsIt’s the basic rule of medicine all doctors follow – ‘first do no harm’. New research from a collaboration between Australian and New Zealand researchers backs that premise, showing that…